|
|
Volumn 330, Issue 6012, 2010, Pages 1736-1739
|
|
What's next for disease eradication?
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIFILARIAL AGENT;
POLIOMYELITIS VACCINE;
SEVERE ACUTE RESPIRATORY SYNDROME VACCINE;
SMALLPOX VACCINE;
DISEASE VECTOR;
ENZYME ACTIVITY;
MOLECULAR ANALYSIS;
ARTICLE;
DISEASE TRANSMISSION;
DRACUNCULIASIS;
EPIDEMIOLOGICAL DATA;
ERADICATION THERAPY;
FILARIASIS;
FUNDING;
GEOGRAPHIC DISTRIBUTION;
HEALTH PROMOTION;
HUMAN;
POLIOMYELITIS;
POLIOMYELITIS VIRUS;
PRIORITY JOURNAL;
PROGRAM DEVELOPMENT;
SARS CORONAVIRUS;
SEVERE ACUTE RESPIRATORY SYNDROME;
SMALLPOX;
VACCINATION;
WORLD HEALTH ORGANIZATION;
HEALTH;
INFECTION CONTROL;
LYMPHATIC FILARIASIS;
MALARIA;
MEASLES;
NOTE;
PUBLIC HEALTH;
COMMUNICABLE DISEASE CONTROL;
DRACUNCULIASIS;
ELEPHANTIASIS, FILARIAL;
HUMANS;
MALARIA;
MEASLES;
POLIOMYELITIS;
PUBLIC HEALTH;
SMALLPOX;
WORLD HEALTH;
|
|
EID: 78650659494
PISSN: 00368075
EISSN: 10959203
Source Type: Journal
DOI: 10.1126/science.330.6012.1736 Document Type: Article |
|
Times cited : (14)
|
|
References (0)
|
